DelveInsight’s Night Vision Disturbances market report offers comprehensive coverage of the current treatment practices, emerging drugs, Night Vision Disturbances market share of the individual therapies, current and forecasted Night Vision Disturbances market size from 2018 to 2030 segmented into 7MM (the United States, EU5 (Germany, Spain, Italy, France, and the UK), and Japan).
Some of the Key Highlights from the Night Vision Disturbances Market Report
-
As per DelveInsight’s Night Vision Disturbances epidemiology insights, the total incident cases were estimated to be 3,128,058 in the 7MM in 2020.
-
Among the EU5 countries, France had the highest Night Vision Disturbances incident cases in 2020.
-
Key players such as Ocuphire Pharma and others are diligently working toward the development of novel therapies for Night Vision Disturbances.
-
Nyxol (Ocuphire Pharma) is a novel eye drop treatment for a variety of front-of-the-eye disorders such as NVD, glaucoma, and medically induced mydriasis.
Have queries? Request for sample @ Night Vision Disturbances Market Outlook
The Night Vision Disturbances market report also discusses current Night Vision Disturbances treatment practices/algorithms, Night Vision Disturbances market drivers, Night Vision Disturbances market barriers, and unmet medical needs.
Night Vision Disturbances: Overview
The term Night Vision Disturbance (NVD) refers to a decrease in vision quality caused by glare disability, with decreased contrast sensitivity and resulting image degradation.
As patients’ awareness and demands grew in response to the dramatic increase in the incidence of corneal refractive surgery engendered by the “LASIK revolution,” aided and abetted by modern communications, NVD became more of an issue.
Night Vision Disturbances Epidemiology Segmentation
The Night Vision Disturbances report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:
-
Night Vision Disturbances Total Incident Cases
-
Night Vision Disturbances Incident Cases by Type of Surgeries
-
Incidence of Night Vision Disturbances Manifestations
Night Vision Disturbances Treatment Landscape
There is no effective treatment for Night Vision Disturbance. For NVD diagnosis, ophthalmologists typically examine patients’ eyes and test their vision. The current NVD therapeutics market has been divided into two segments based on the therapeutic classes- miotics (such as pilocarpine, carbachol, and aceclidine) and adrenergic agonists (such as brimonidine tartrate).
Night Vision Disturbances Market
-
The NVD market size was found to be USD 282.6 Million in the 7MM in 2020.
-
Among the 7MM, the US accounted for 60% of the overall NVD market size in 2020.
-
Among the EU5 countries, France captured the highest NVD market share in 2020.
-
As there are not many approved therapies in the NVD market, Nyxol is expected to create a positive shift and drive the NVD market during the forecast period (2021–2030).
Find out more about the market @ Night Vision Disturbances Market Share
Night Vision Disturbances Pipeline Therapies and Key Companies
-
Nyxol: Ocuphire Pharma
Night Vision Disturbances Market Drivers
-
Market share potential
-
Rising NVD incidence
-
Increased Awareness
Night Vision Disturbances Market Barriers
-
Poor pipeline
-
Insufficient literature
-
Challenges in treatment
Scope of the Report
Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan)
Study Period: 2018-30
Night Vision Disturbances Key Companies: Ocuphire Pharma, among others.
Night Vision Disturbances Key Pipeline Therapies: Nyxol, and others.
Night Vision Disturbances Segmentation: By Geography, Night Vision Disturbances drugs
Analysis: Comparative and conjoint analysis of Night Vision Disturbancesemerging therapies
Tools Used: SWOT Analysis
Case Studies
KOL’s Views
Analyst’s Views
Table of Contents
|
1. |
Key Insights |
|
2. |
Report Introduction |
|
3. |
Night Vision Disturbances Market Overview at a Glance |
|
4. |
Executive Summary of Night Vision Disturbances |
|
5. |
NVD Market: Future Perspective |
|
6. |
Night Vision Disturbances Disease Background and Overview |
|
7. |
Night Vision Disturbances Epidemiology and Patient Population |
|
8. |
Night Vision Disturbances Treatment |
|
9. |
Organizations contributing towards Night Vision Disturbances |
|
10. |
Case Reports |
|
11. |
Patient Journey |
|
12. |
Night Vision Disturbances Emerging Therapies |
|
13. |
Night Vision Disturbances: 7 Major Market Analysis |
|
14. |
KOL Views |
|
15. |
Night Vision Disturbances Market Drivers |
|
16. |
Night Vision Disturbances Market Barriers |
|
17. |
SWOT Analysis |
|
18. |
Night Vision Disturbances Unmet Needs |
|
19. |
Appendix |
|
20. |
DelveInsight Capabilities |
|
21. |
Disclaimer |
|
22. |
About DelveInsight |
For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare, and Biotech Blog Posts
Related Reports
Age-related Vision Dysfunction Market
Get a comprehensive analysis of Age-related Vision Dysfunction pipeline therapies and key companies such as Allergan, Orasis Pharmaceuticals, Eyenovia, Alkeus Pharmaceuticals, Roche, Kodiak Sciences, Novartis, among others.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/